Sevelamer, a phosphate binder widely given to manage hyperphosphatemia, presents a unique clinical paradox. Its process involves binding to dietary phosphate in the digestive tract , preventing its uptake https://priyanka-dhingra324916.newsyblog.com/890733/sevelamer-when-medication-looks-like-disorder